Clinical Trial Update: Neural and Antidepressant Effects of Propofol [Phase 2, Phase 3]

View source ↗

Summary

This is a clinical trial update on Phase 2 and Phase 3 studies evaluating the neural and antidepressant effects of propofol in treatment-resistant depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• PROPOFOL (Propofol)

Snippet

Sponsor: University of Utah | Conditions: Treatment Resistant Depression | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING